Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most commonly reported bad side effects from Wegovy are gastrointestinal: nausea, vomiting, diarrhoea, constipation and stomach discomfort. They tend to be most noticeable when you first start treatment or step up to a higher dose, and they usually ease within days to a couple of weeks as your body adjusts. That said, some people find them genuinely difficult, and a small number experience rarer but more serious reactions that need medical attention promptly. Wegovy (semaglutide) is a prescription-only medicine, so any questions about managing side effects on your own treatment should go to your prescriber or the Patient Information Leaflet supplied with your pen — the detail here is educational, not personal medical advice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The majority of people taking Wegovy report at least one gastrointestinal side effect, particularly in the early months of treatment. The most frequent are nausea, vomiting, diarrhoea, constipation and acid reflux or indigestion. Burping and a general feeling of fullness that tips into discomfort are also common. The full Wegovy side-effect profile is well characterised from the STEP clinical trials and is summarised on the NHS semaglutide medicines page.
Headache, fatigue and dizziness appear in clinical data too, though less reliably than the GI effects. Injection-site redness or mild discomfort is possible with any subcutaneous injection and usually settles quickly. A question our prescribers hear most weeks is whether these effects are a sign that something is wrong — in most cases they are not, and they reflect the medicine doing exactly what it is designed to do: slowing gastric emptying and signalling fullness through GLP-1 receptors. That mechanism is also why eating smaller meals, avoiding very fatty or spicy food, and staying well hydrated tends to reduce the severity of symptoms.
If you are curious how the GI pattern compares to semaglutide in a different form, the semaglutide side-effect overview covers the shared pharmacology behind the symptoms.
Timing is the thing most people find reassuring once they know it. Side effects from Wegovy are generally most pronounced in two windows: the first week or two after starting, and the days following each dose increase. During those periods, nausea in particular can be quite intrusive. The good news is that for the majority of people the symptoms are transient rather than permanent features of treatment.
Some people find that slowing the dose-escalation pace gives their system more time to adapt. That is a clinical decision, your prescriber can adjust the titration timetable based on how you're tolerating each step. It is not something to manage by skipping doses unilaterally, because the dose schedule exists for a reason and any change should be discussed with the clinician responsible for your care.
A smaller group does not find the symptoms settle, even at lower doses. If that is your experience, the right conversation is with your prescriber about whether the benefit-risk balance still makes sense or whether an alternative approach is warranted. You can read more about how Wegovy side effects present over time, and about the experiences of people who find them more manageable than expected at our page on Wegovy and minimal side effects.
Most side effects are unpleasant rather than dangerous. A smaller number are genuinely serious and need prompt action.
Pancreatitis is the one the MHRA has highlighted specifically for GLP-1 medicines. In January 2026 the MHRA issued a Drug Safety Update reminding prescribers and patients that acute pancreatitis, while infrequent, can be severe. The symptom to know is persistent, intense pain in the upper abdomen that radiates through to the back, sometimes with vomiting. This is not typical Wegovy nausea. If you experience it, stop taking your injection and get medical help the same day; do not wait to see if it passes. The MHRA's guidance is available via the Drug Safety Update index on GOV.UK.
Gallbladder problems (pain in the upper-right abdomen, fever, jaundice) have been reported with GLP-1 medicines and also need medical assessment rather than watchful waiting.
Allergic reactions can range from mild skin reactions to rare anaphylaxis. Swelling of the face, lips or throat, difficulty breathing, or a rapid severe rash after injection require emergency care.
Dehydration from prolonged vomiting or diarrhoea can put kidney function under strain. Signs include dizziness on standing, reduced urination and extreme thirst, contact your GP or prescriber promptly. A full breakdown of serious warning signs is at our dedicated serious side-effects page.
Understanding what the side-effect picture looks like (the likely, the possible, and the rare but serious) is a reasonable thing to want before committing to any medicine. It is also part of what a prescriber is there to discuss with you, not a reason to delay getting a clinical opinion.
Private treatment for Wegovy begins with a consultation, where your full medical history, current medicines and circumstances are reviewed before any prescription is issued. At our pharmacy every consultation is read by a GPhC-registered Independent Prescriber, not automated software, and side-effect management is part of the aftercare we offer seven days a week. If you are still at the research stage, the Wegovy overview page covers how the treatment works and who it is licensed for, and our weight-loss treatments page sets out the options side by side.
If cost is part of your thinking alongside safety, our Wegovy price comparison guide explains what a legitimate private prescription should include. And if you are ready to talk through whether Wegovy is appropriate for you, starting a free consultation puts your case in front of a real prescriber the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.